EMERGENT BIOSOLUTIONS INC. COMMON STOCK

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

15 Sep 2026 07:45:03 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

10 Aug 2026 09:45:41 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

07 Aug 2026 12:51:10 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 Aug 2026 09:46:32 By NetDania Notify

Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness

14 Jan 2026 08:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation

12 Jan 2026 07:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

08 Jan 2026 16:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

08 Jan 2026 08:00:01 By Nasdaq GlobeNewswire

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

07 Jan 2026 09:45:47 By NetDania Notify

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

07 Jan 2026 07:59:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 Jan 2026 10:15:42 By NetDania Notify

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

12 Dec 2025 08:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

18 Nov 2025 08:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

12 Nov 2025 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

30 Oct 2025 10:36:24 By NetDania Notify

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

29 Oct 2025 16:15:01 By Nasdaq GlobeNewswire

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

28 Oct 2025 08:00:01 By Nasdaq GlobeNewswire

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

08 Oct 2025 07:45:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

24 Sep 2025 16:05:42 By Nasdaq GlobeNewswire

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

19 Sep 2025 08:34:54 By Nasdaq GlobeNewswire